Novo Nordisk stock fell as much as 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target.
原文: https://www.cnbc.com/2026/02/23/novo-nordisk-stock-cagrisema-trial-fails-weight-loss.html
Last Update:
23 2 月, 2026
